Cytomegalovirus Retinitis

Symptoms

Common signs and symptoms of Cytomegalovirus Retinitis include:

Blurred vision that gets progressively worse

Seeing flashing lights or bright spots

Dark spots or shadows in the field of vision

Blind spots that expand over time

Loss of side (peripheral) vision

Difficulty seeing objects clearly

Seeing floating spots or cobwebs

Light sensitivity and eye discomfort

Sudden decrease in vision quality

Complete vision loss in affected areas

Eye redness or irritation

Seeing curved lines as wavy or distorted

When to see a doctor

If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.

Causes & Risk Factors

Several factors can contribute to Cytomegalovirus Retinitis.

Cytomegalovirus retinitis develops when the normally dormant CMV virus reactivates and spreads to the eyes.

Cytomegalovirus retinitis develops when the normally dormant CMV virus reactivates and spreads to the eyes. Most people become infected with CMV during childhood or young adulthood through contact with infected body fluids like saliva, blood, urine, or breast milk. The virus then remains inactive in the body for life, kept in check by a healthy immune system.

When the immune system becomes severely compromised, CMV can reactivate and travel through the bloodstream to various organs, including the eyes.

When the immune system becomes severely compromised, CMV can reactivate and travel through the bloodstream to various organs, including the eyes. The virus specifically targets the retinal cells, causing inflammation and tissue death. This process typically starts in one eye but can spread to both eyes if left untreated.

The most common trigger for CMV retinitis is advanced HIV infection, particularly when CD4 cell counts drop below 50 cells per microliter.

The most common trigger for CMV retinitis is advanced HIV infection, particularly when CD4 cell counts drop below 50 cells per microliter. Other conditions that can weaken the immune system enough to allow CMV reactivation include organ transplantation with immunosuppressive therapy, certain cancers like leukemia or lymphoma, and prolonged high-dose corticosteroid treatment. In rare cases, people born with severe immune deficiencies may develop CMV retinitis early in life.

Risk Factors

HIV infection with very low CD4 counts (below 50)
Organ transplant recipients taking immunosuppressive drugs
Blood or bone marrow transplant patients
Cancer patients receiving chemotherapy
Long-term high-dose corticosteroid treatment
Congenital immunodeficiency disorders
Previous CMV infection in other organs
Not taking HIV medications as prescribed
Advanced age in immunocompromised patients
Severe malnutrition affecting immune function

Diagnosis

How healthcare professionals diagnose Cytomegalovirus Retinitis:

1
Diagnosing CMV retinitis requires a comprehensive eye examination by an ophthalmologist or retinal specialist.
Diagnosing CMV retinitis requires a comprehensive eye examination by an ophthalmologist or retinal specialist. The doctor will dilate the pupils and use specialized instruments to examine the retina in detail. CMV retinitis has a characteristic appearance that experienced eye doctors can often recognize immediately - areas of white or yellow retinal tissue death, often described as having a "pizza pie" or "cottage cheese and ketchup" appearance due to the mix of white infected areas and red hemorrhages.
2
Several tests help confirm the diagnosis and assess the extent of the infection.
Several tests help confirm the diagnosis and assess the extent of the infection. Optical coherence tomography (OCT) provides detailed cross-sectional images of the retina, while fluorescein angiography uses special dye to highlight blood vessel damage. In some cases, doctors may take a sample of fluid from inside the eye (vitreous tap) to test for CMV DNA using polymerase chain reaction (PCR) testing. Blood tests can measure CMV viral load and assess immune system function.
3
Photographic documentation of the retina helps track disease progression and treatment response over time.
Photographic documentation of the retina helps track disease progression and treatment response over time. Regular monitoring is essential because CMV retinitis can progress rapidly, sometimes causing irreversible vision loss within days or weeks. Early diagnosis gives patients the best chance of preserving their sight and preventing the infection from spreading to the unaffected eye.

Complications

The most serious complication of CMV retinitis is permanent vision loss, which can range from small blind spots to complete blindness in the affected eye.
Even with prompt treatment, some degree of vision loss often occurs because damaged retinal tissue cannot regenerate.
The infection typically progresses from the outer edges of the retina toward the center, so early treatment is crucial to preserve central vision needed for reading and detailed tasks.
Retinal detachment represents another significant risk, occurring in about 20-30% of patients with CMV retinitis.
This happens when the infection weakens the retina enough that it separates from the underlying tissue.
Retinal detachment requires emergency surgical repair to prevent permanent blindness, though vision may not return to normal even after successful surgery.
Other eye complications can include increased eye pressure (glaucoma), cataracts, and inflammation of other eye structures.

Prevention

Preventing CMV retinitis centers on maintaining a strong immune system and avoiding CMV infection when possible.
For people with HIV, taking antiretroviral medications consistently and achieving an undetectable viral load dramatically reduces the risk of developing CMV retinitis and other opportunistic infections.
Regular medical monitoring helps catch immune system problems early, before they become severe enough to allow CMV reactivation.
General infection prevention measures can help reduce the risk of acquiring CMV in the first place.
These include washing hands frequently, avoiding sharing drinks or eating utensils, and practicing safe sex.
Pregnant women should be especially careful around young children, who commonly shed CMV in their saliva and urine.
Healthcare workers and others who care for immunocompromised patients should follow standard infection control precautions.
For people already at high risk due to immunosuppression, regular eye exams can help detect CMV retinitis early when treatment is most effective.
Some doctors recommend monthly dilated eye exams for patients with very low CD4 counts or other severe immune deficiencies.
Prophylactic antiviral treatment may be considered for extremely high-risk patients, though this approach requires careful evaluation of benefits versus potential side effects.

Treatment Approaches

Treatment for CMV retinitis focuses on controlling the viral infection and preventing further retinal damage.

Treatment for CMV retinitis focuses on controlling the viral infection and preventing further retinal damage. The standard approach involves antiviral medications that can be given intravenously, orally, or directly injected into the eye. Ganciclovir and foscarnet are the most commonly used antiviral drugs, often given through a central venous catheter for several weeks during the initial treatment phase.

Medication

Direct injection of antiviral medication into the eye (intravitreal injection) has become increasingly popular because it delivers high concentrations of drug directly to the infected tissue while minimizing side effects.

Direct injection of antiviral medication into the eye (intravitreal injection) has become increasingly popular because it delivers high concentrations of drug directly to the infected tissue while minimizing side effects. Some patients receive a sustained-release ganciclovir implant that slowly releases medication into the eye over several months. This approach can be particularly useful for people who cannot tolerate systemic antiviral drugs.

Medication

For patients with HIV-related CMV retinitis, starting or optimizing antiretroviral therapy is equally important.

For patients with HIV-related CMV retinitis, starting or optimizing antiretroviral therapy is equally important. As the immune system recovers, it can help fight the CMV infection naturally. However, this immune recovery can sometimes cause temporary worsening of eye inflammation, requiring careful monitoring and possibly anti-inflammatory treatment.

TherapyAnti-inflammatory

Long-term maintenance therapy is usually necessary to prevent CMV retinitis from returning.

Long-term maintenance therapy is usually necessary to prevent CMV retinitis from returning. Treatment typically continues until the immune system recovers sufficiently (CD4 counts above 100-150 for at least 6 months in HIV patients). Regular follow-up appointments every 2-4 weeks allow doctors to monitor treatment response and watch for signs of progression or complications. New antiviral drugs and treatment approaches continue to be developed, offering hope for improved outcomes.

MedicationTherapy

Living With Cytomegalovirus Retinitis

Living with CMV retinitis requires ongoing medical care and lifestyle adaptations to preserve remaining vision. Regular follow-up appointments with both eye specialists and doctors managing the underlying immune condition are essential. Many patients benefit from low-vision rehabilitation services, which teach techniques for making the most of remaining eyesight and using adaptive devices like magnifiers or special lighting.

Practical adaptations can help maintain independence and safety.Practical adaptations can help maintain independence and safety. These include improving home lighting, using high-contrast colors for important items, organizing belongings in consistent locations, and considering mobility aids if peripheral vision is affected. Many patients find that joining support groups for people with vision loss provides valuable practical tips and emotional support from others facing similar challenges.

Maintaining overall health becomes even more important for people with CMV retinitis.Maintaining overall health becomes even more important for people with CMV retinitis. This includes taking all medications as prescribed, eating a nutritious diet, getting adequate rest, and avoiding activities that might further compromise immune function. Working with healthcare providers to optimize treatment for HIV or other underlying conditions can help prevent CMV retinitis from returning or affecting the other eye. Many people with stable, treated CMV retinitis can continue working and enjoying many of their usual activities with appropriate accommodations.

Latest Medical Developments

Latest medical developments are being researched.

Frequently Asked Questions

Can CMV retinitis spread from person to person?

CMV retinitis itself cannot spread between people, but the CMV virus can be transmitted through body fluids like saliva, blood, and urine. However, CMV retinitis only develops in people with severely compromised immune systems.

Will my vision return to normal after treatment?

Treatment can stop the progression of CMV retinitis and prevent further vision loss, but damaged retinal tissue cannot regenerate. The amount of vision recovery depends on how much damage occurred before treatment began.

How often will I need eye injections?

The frequency of eye injections varies based on the specific medication and your response to treatment. Initially, injections may be needed weekly or every other week, then less frequently as the infection is controlled.

Can CMV retinitis affect both eyes?

Yes, CMV retinitis can affect both eyes, either at the same time or sequentially. About 50% of patients eventually develop the infection in both eyes if left untreated.

Is it safe to drive with CMV retinitis?

Driving safety depends on how much vision loss has occurred and which areas of the retina are affected. You should discuss this with your eye doctor and may need a vision test to determine if you meet legal driving requirements.

What are the side effects of CMV retinitis medications?

Side effects vary by medication but can include kidney problems, low white blood cell counts, anemia, and nausea. Eye injections may cause temporary eye pressure increases or floaters.

How long will I need treatment?

Treatment duration depends on your immune system recovery. Most people need maintenance therapy until their immune system strengthens sufficiently, which can take months to years.

Can I prevent CMV retinitis from coming back?

Maintaining a strong immune system through proper HIV treatment or immune system management greatly reduces the risk of recurrence. Regular eye exams help catch any reactivation early.

Should I avoid certain activities with CMV retinitis?

You should avoid activities that could cause eye injury and may need to modify activities requiring good peripheral vision. Your doctor can provide specific guidance based on your vision loss pattern.

What should I do if my vision suddenly gets worse?

Contact your eye doctor immediately if you experience sudden vision changes, new blind spots, or flashing lights. Rapid progression of CMV retinitis requires urgent medical attention to prevent permanent damage.

Update History

Mar 16, 2026v1.0.0

Published page overview and treatments by DiseaseDirectory